|
Rare disease consultation to launch |
|
Saturday, 29 March 2008 |
Plans for a European Commission consultation on the future of the treatment of rare diseases have been unveiled at a conference in Lisbon, Portugal.
The European Organisation for Rare Diseases (Eurodis), which organised the event to discuss topics concerning the millions of people living with unusual medical conditions, said that it had helped contribute to the creation of a new European Union Communication designed to help countries form policies to deal with rare diseases.
|
|
Read more...
|
|
|
HIV drug comparison trials launch |
|
Sunday, 10 February 2008 |
A new clinical trial comparing two categories of anti-retroviral medications has been launched in the US, it has been announced.
Patients with HIV sometimes develop cognitive disorders as a result of the infection attacking their brain and central nervous system (CNS).
|
|
Read more...
|
|
|
Anti viral drug for RSV infection achieves Phase I results |
|
Monday, 17 December 2007 |
Positive results have been released for the trial of a new anti viral drug designed for RSV infection.
Data from the Phase I inhalation trials of ALN-RSV01 were made public at the 18th Annual Drug Delivery to the Lungs meeting held in Edinburgh, with delegates being told that all major objectives were achieved. |
|
Read more...
|
|
|
New study for arthritis drugs |
|
Monday, 17 December 2007 |
Dundee University is spearheading a £26 million trial investigating the safety and efficacy of medication for arthritis, which currently affects about nine million predominantly elderly people in the UK.
Under the Standard care versus Celecoxib Outcome Trial (SCOT), academics from the university are to compare traditional anti-inflammatory drugs such as ibuprofen with the newly-developed counterpart celecoxib. |
|
Read more...
|
|
|
|
